52
OS Therapies raises $12.28M in biotech offering under Reg D 506(b)
Company raise · Raising · Offering $12.3M · Sold $7.2M · GRASONVILLE, MD · filed 2026-10-23
Placement agent engaged
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Avril P. McKean Dieser | Director |
| John P. Ciccio | Director |
| Christopher P. Acevedo | Chief Financial Officer |
| Theodore F. Search | Director |
| Paul A. Romness | Founder, Chairman, President and Chief Executive Officer |
| Robert G. Petit | Chief Medical Officer and Chief Scientific Officer |
| Gerald P. Commissiong | Chief Business Officer |
| Olivier R. Jarry | Director |
Signed by Paul A. Romness, Chief Executive Officer.
Placement agents / sales compensation: Brookline Capital Markets; Ceros Financial Services, Inc.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.